Eternex-T Tablet contains Teneligliptin 20mg, an oral antihyperglycemic agent used primarily for the management of type 2 diabetes mellitus. Teneligliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by enhancing the levels of incretin hormones, thereby increasing insulin secretion and decreasing glucagon release in a glucose-dependent manner. This dual action helps to regulate blood sugar levels effectively without causing significant hypoglycemia. Eternex-T is typically prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, either as monotherapy or in combination with other antidiabetic medications. The tablet is taken orally, usually once daily, with or without food, ensuring patient compliance and convenience. Teneligliptin has a favorable safety profile, with minimal risk of weight gain and a low incidence of adverse effects such as gastrointestinal disturbances. Regular monitoring of blood glucose and renal function is recommended during therapy. Eternex-T offers a modern, effective option for managing type 2 diabetes, helping patients achieve better glycemic control and reduce the risk of diabetes-related complications. Always use under medical supervision.